Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

Anemia is a frequent complication of cancer and its treatment. Based on updated and new chapters, including a broader spectrum of topics, outstanding international experts describe the scientific and clinical aspects of anemia in various fields of oncology and give diagnostic and therapeutic recommendations on when and how to use rhEPO.